Biomonitoring of Phthalates, Bisphenols and Parabens in Children: Exposure, Predictors and Risk Assessment

Pablo Dualde1, Nuria León2, Yovana Sanchis2

  • 1Foundation for the Promotion of Health and Biomedical Research of the Valencian Region, FISABIO-Public Health, Av. Catalunya, 21, 46020 Valencia, Spain.

Insights

Children in Spain are widely exposed to phthalates, bisphenols, and parabens, but internal exposure levels are below health risk guidance values. This biomonitoring study found lower concentrations than previous research, indicating no expected health risks.

Area of Science:

  • Environmental Health
  • Biomonitoring
  • Pediatric Exposure

Background:

  • Emerging contaminants like phthalates, bisphenols, and parabens are linked to neurodevelopment and endocrine issues in children.
  • Biomonitoring of these contaminants in children is crucial for assessing exposure and potential health risks.

Purpose of the Study:

  • To biomonitor exposure to phthalates, bisphenols, and parabens in children aged 5-12 years in the Valencia Region, Spain.
  • To assess the internal exposure levels and evaluate potential health risks associated with these emerging contaminants.

Main Methods:

  • Utilized urine samples from the BIOVAL program for biomonitoring.
  • Analyzed biomarkers for phthalates, bisphenols, and parabens in 562 children.
  • Calculated geometric means (GM) for detected compound concentrations.

Main Results:

  • Over 75% of children showed exposure to bisphenols and parabens (>LOQ).
  • All assessed children (n=557) were exposed to at least one phthalate.
  • Detected concentrations were generally lower than in previous national and international studies.

Conclusions:

  • Widespread exposure to phthalates, bisphenols, and parabens was confirmed in the studied child population.
  • Internal exposure levels were below established guidance values, suggesting no anticipated health risk.
  • Biomonitoring data indicates a potentially decreasing trend in exposure compared to prior research.

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
204
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
2.6K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
40
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
44
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.3K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
34